跳至主要内容
临床试验/NCT07102797
NCT07102797招募中不适用

ActiveGirls: Physical Activity, Hormone Health, and Diabetes Risk in Early Adolescence

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
2
主要终点
Retention

研究概览

简要总结

This study explores how a physical activity program can affect hormone health and diabetes risk in girls ages 8-12 who may be at higher risk. The study aims to address:

  • Does the 'ActiveGirls' program meet the needs of girls and families in engaging them to increase physical activity?
  • What is the trend of markers of diabetes risk and puberty hormones over a 1-year period and how are these levels related to physical activity levels?

Participants in this study will either:

  • Participate in a 'full' intensity intervention that includes educational messages (text/email) as well as health coaching visits to support physical activity over a 6 month period
  • Participate in a delayed 'lower intensity' intervention that includes only educational messages (text/email)
  • Participants in both groups will complete at-home activity monitoring, two study visits for check-ups and tests, and surveys

详细描述

This study is a pilot randomized trial to assess the preliminary feasibility and efficacy of a physical activity intervention enrolling peripubertal females.

Participants will be assigned to the intensive intervention group with text messaging and health coaching versus delayed lower intensity comparison group with a lower intensity text-only intervention. Participants in both arms will complete objective measures of body composition, insulin dynamics, reproductive hormones, physical activity and fitness over a one-year period. Participants as well as a caregiver proxy will complete survey measures addressing lifestyle behaviors and social-emotional wellness. Given evidence suggesting increased effectiveness of whole-family lifestyle interventions, a parent/caregiver will assist with child participation in the ActiveGirls program, including facilitating health coaching visits and at-home physical activity sessions. assist in intervention delivery and outcomes assessment.

After the baseline visit, there are 2 more study assessment points at 6-months and 12-months. The baseline and 12-month assessments require in-person visits to the MGH Translational and Clinical Research Centers (TCRC); the 6-month assessment is performed remotely. All study visits will occur at MGH.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
8 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Caregiver: Caregiver of child (ie mother, father, or other legal guardian), English-speaking, Access to a device where they are able to receive study e-mails or texts
  • •Child: English-speaking, Female, ages 8-12 years old at time of enrollment, Pre-menarchal at time of baseline visit, at risk for Polycystic Ovary Syndrome (PCOS)/insulin resistance, as defined by (1) History of maternal PCOS/maternal GDM, (2) BMI >/= 85th percentile, (3) History of premature adrenarche, or (4) Small (<10th %ile) for gestational age

排除标准

  • •Medications at time of enrollment: Metformin, GLP-1R Agonist, Insulin, GnRH agonist
  • •Endocrine conditions that would impact either insulin sensitivity, androgen concentrations, or growth
  • •Insulin dynamics: Type 1 diabetes, Type 2 diabetes, Congenital Hyperinsulinism
  • •Androgen Conditions: Adrenal tumor, Congenital Adrenal Hyperplasia
  • •Hyperthyroidism or uncontrolled hypothyroidism (TSH >7.0 mIU/mL)
  • •Growth Hormone Deficiency
  • •Medical conditions that would impact PA participation: Type 1 diabetes; Cardiovascular, neurologic, and/or musculoskeletal conditions limiting ability to participate in physical activity.
  • •Other medical comorbidities that would limit generalizability of findings, including: Severe congenital heart disease, Congenital anomalies, Cystic fibrosis, Cerebral palsy, Condition requiring use of nasogastric, gastric tube, or other alternative method of feeding, Undiagnosed conditions with significant impact on child's growth and development; Significant cardiac, hepatic, oncologic, inflammatory, or psychiatric disease.

研究组 & 干预措施

Full Intensity Intervention

Experimental

Participants in this arm will receive the 'full' intensive ActiveGirls intervention, which will include educational messaging (3-4/week, via email or text message) as well as a series of 6 health coaching visits for physical activity goal setting. Participants in this arm will receive the intervention in months 1-6 of their study participation.

干预措施: ActiveGirls Physical Activity Program (Full) (Behavioral)

Delayed lower intensity comparison group

Active Comparator

Participants in this arm will receive a lower intensity educational messaging only intervention in months 7-12 of their study participation. This group will not receive health coaching.

干预措施: ActiveGirls Physical Activity Program (Delayed Lower Intensity) (Behavioral)

结局指标

主要结局

Retention

时间窗: 12 months

Proportion of participants completing each study assessment point/coaching visit divided by total participants enrolled/eligible

Acceptability

时间窗: 12 months

Intervention rating as acceptable by parent-child dyads using validated measure (Acceptability of Intervention Measure (AIM)); The AIM score is reported on a scale of 0-4. 0 is the minimum and 4 is the maximum. Higher scores mean greater intervention acceptability

Retention

时间窗: 12 months

Proportion of participants completing each study assessment point/coaching visit divided by total participants enrolled/eligible

Acceptability

时间窗: 12 months

Intervention rating as acceptable by parent-child dyads using validated measure (Acceptability of Intervention Measure (AIM)); The AIM score is reported on a scale of 0-4. 0 is the minimum and 4 is the maximum. Higher scores mean greater intervention acceptability

次要结局

  • Objectively Measured Physical Activity(6 months, 12 months)
  • Insulin Sensitivity(Change in HOMA-IR from baseline to 12-month follow-up)
  • Free Androgen Index(Baseline to 12 month follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rachel Clare Whooten

Assistant Professor

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验